Stories
Mobility
Scientists Drove Antimatter Down the Highway — and It Survived
A team of physicists drove antiprotons down a road in a magnetic trap — and the implications reach far beyond the novelty of the trip.
Mobility
VW's CEO Declares Physical Controls Non-Negotiable, Signaling a Broader Industry Reckoning
Volkswagen's CEO is scrapping touch controls and abstract model names, and the ripple effects could reshape how the whole industry thinks about cockpit design.
Economy
India Has No Single Growth Model, and That Might Be Its Greatest Strength
India keeps defying every growth template economists hand it, and a provocative new book argues that might be the whole point.
Economy
Iran Opens Hormuz to Iraqi Tankers, Threatening to Flood an Already Fragile Oil Market
Tehran's decision to grant Iraqi ships Hormuz transit rights could release 3 million barrels per day into markets already straining under OPEC+ tensions.
Mobility
Nissan's e-Power Bet: A Hybrid That Runs Like an EV But Drinks Like a Gas Car
Nissan's e-Power hybrid never lets the gas engine touch the wheels — and that unusual bet could decide whether the brand recovers its American footing.
Health
A single gene therapy injection is reversing congenital deafness within weeks
A single injection delivering a corrected hearing gene restored function in all ten patients tested, raising profound questions about biology, identity, and access.
More Stories
Mobility
Tesla's 50,000-Vehicle Inventory Glut Signals Deeper Demand Pressures Ahead
Mobility
Jaguar's Six-Figure Electric Gamble Bets Prestige Over Volume
Mobility
BMW Helped Invent the Range-Extended EV. Now It's Watching Others Profit From the Idea
Mobility
The EV Graveyard Is Growing, and It Reveals More Than a Sales Slump
Advertisementinfeed_2
Mobility
Waymo's Ridership Doubles in a Year, and the Ripple Effects Are Just Beginning
Waymo just hit 500,000 driverless rides a week — and the systems it is about to disrupt extend far beyond the taxi industry.
Health
Zombie Cells and the Science Trying to Clear Them Before They Kill You
Cells that stop dividing but refuse to die are now central to aging science, and the drugs targeting them could reshape medicine or create new problems.